Impedimed LimitedASX: IPD

2026 Annual Report

Aug 26, 2026 at 9:06 PM EDT · Issued by ImpediMed Limited via ASX

Filed with ASX · Aug 26, 2026 at 9:06 PM EDT

On 6ix: 6ix.com/news/2026-annual-report-69

Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29 Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call

ImpediMed Limited Suite 31C, 12-18 Tryon Rd Lindfield NSW 2070 Australia E: investorrelations@impedimed.com W : impedimed.com 27 August 2026 Companies Announcements Office Australian Securities Exchange 2026 Annual Report ImpediMed Limited (ASX:IPD) is pleased to...

View Attachment

6ix hasn’t read this filing yet.

Impedimed Limited on 6ix

Story so far

FY26 Half Year Financial ResultsFeb 26, 2026
ImpediMed 2024 Half-Year Financial ResultsFeb 27, 2024

Earlier from Impedimed

Appendix 4EAug 26
FDA Clearance for Sarcopenia Risk Assessment ReceivedAug 18
ASX Listing Rule 7.16 ComplianceAug 13
Notification of cessation of securities - IPDAug 6
Quarterly Activities Report and Appendix 4C - Jun-2026 QtrJul 27

Later from Impedimed

Appendix 4G and Corporate Governance StatementAug 26
Date of 2026 Annual General MeetingSep 10
Update on OptionsSep 23
Change of Director's Interest Notice - Mr Erik AndersonSep 29
Notice of Initial Substantial HolderOct 1

All Impedimed news releases

Follow Impedimed into a list and get an email when it puts out news.

Follow Impedimed